Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival

Nature Communications

Volumn 7, Issue , 2016, Pages

  Gaude, Edoardo ^a   Frezza, Christian ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

BIOTRANSFORMATION; CANCER; CELLS AND CELL COMPONENTS; GENE EXPRESSION; METABOLISM; MITOCHONDRIAL DNA; SURVIVAL;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CITRIC ACID CYCLE; CLINICAL OUTCOME; CONTROLLED STUDY; CUTANEOUS MELANOMA; DNA SYNTHESIS; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FATTY ACID OXIDATION; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; MALIGNANT TRANSFORMATION; METABOLISM; METASTASIS POTENTIAL; METASTATIC MELANOMA; MITOCHONDRIAL GENE; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PYRIMIDINE SYNTHESIS; TISSUE SPECIFICITY; TUMOR INVASION; UPREGULATION; UREA CYCLE; ANTIBODY SPECIFICITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; NEOPLASM; PATHOLOGY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR CELL LINE;

CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; ORGAN SPECIFICITY; OXIDATIVE PHOSPHORYLATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84990990084     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13041     Document Type: Article

References (32)

1. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558 (2013).
2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
3. Warburg, O. Uber den Stoffwechsel der Carcinomzelle. Naturwissenschaften 12, 1131-1137 (1924).
4. Hu, J. et al. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat. Biotechnol. 31, 522-529 (2013).
5. Jain, M. et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040-1044 (2012).
6. Love, M. I. et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
7. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
8. Terunuma, A. et al. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J. Clin. Invest. 124, 398-412 (2014).
9. Cowley, G. S. et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Sci. data 1, 140035 (2014).
10. Tsai, J. H. & Yang, J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 27, 2192-2206 (2013).
11. LeBleu, V. S. et al. PGC-1a mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 16, 992-1003 (2014).
12. Torrano, V. et al. The metabolic co-regulator PGC1a suppresses prostate cancer metastasis. Nat. Cell Biol. 18, 645-656 (2016).
13. Vanharanta, S. et al. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat. Med. 19, 50-56 (2013).
14. Hakimi, A. A. et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell 29, 104-116 (2016).
15. Reznik, E. & Sander, C. Extensive decoupling of metabolic genes in cancer. PLoS Comput. Biol. 11, e1004176 (2015).
16. Gross, A. M., Kreisberg, J. F. & Ideker, T. Analysis of matched tumor and normal profiles reveals common transcriptional and epigenetic signals shared across cancer types. PLoS ONE 10, e0142618 (2015).
17. Selak, M. A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7, 77-85 (2005).
18. Reznik, E. et al. Mitochondrial DNA copy number variation across human cancers. Elife 5, e10769 (2016).
19. Bartesaghi, S. et al. Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells. Proc. Natl Acad. Sci. USA 112, 1059-1064 (2015).
20. Morais, R. et al. Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res. 54, 3889-3896 (1994).
21. Tan, A. S. et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 21, 81-94 (2015).
22. Metallo, C. M. et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380-384 (2012).
23. Mullen, A. R. et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385-388 (2012).
24. Fendt, S.-M. et al. Reductive glutamine metabolism is a function of the a-ketoglutarate to citrate ratio in cells. Nat. Commun. 4, 2236 (2013).
25. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
26. Porporato, P. E. et al. A mitochondrial switch promotes tumor metastasis. Cell Rep. 8, 754-766 (2014).
27. Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382-387 (2014).
28. Sharma, A. K., Eils, R. & König, R. Copy number alterations in enzyme-coding and cancer-causing genes reprogram tumor metabolism. Cancer Res 76, 4058-4067 (2016).
29. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol. 15, 1-21 (2014).
30. Duarte, N. C. et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl Acad. Sci. USA 104, 1777-1782 (2007).
31. Väremo, L., Nielsen, J. & Nookaew, I. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res. 41, 4378-4391 (2013).
32. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18, S96-S104 (2002).